HMA - Heads of Medicines Agencies
  • RSS
  • Sitemap
  • Login (HMA-DMS)
  • Contact
  • About HMA
  • Human Medicines
  • Veterinary Medicines
  • You are here:
  • Home
  • >Veterinary Medicines
  • >CMDv
  • >Procedural guidance
  • >Applications for Marketing Authorisation
  • >Advice on specific application types
  • CMDv
    • About CMDv
    • Implementation of the VMP Regulation
    • BREXIT
    • Procedural Contact Points
    • Procedural guidance
      • General Information on Applications
      • Validation of Applications
      • Applications for Marketing Authorisation
        • Authorisation procedures
        • Advice on specific application types
        • Clock start dates
      • Post Marketing Procedures
      • CMDv Review Procedure and Referrals
      • Re-examination after DCP/VRA
      • Parallel trade
      • SPC Harmonisation
      • ASMF
      • SPC, Labelling and Package leaflet
      • Borderline products
      • Miscellaneous
    • Questions & Answers
    • Publications
    • Union Product Database (UPD)
  • VMRI Product Index
  • National Contacts

 

Advice on specific application types

Guidance documents - Regulation (EU) 2019/6

Generics 

Guidance for processing of generic and hybrid applications through MRP / SRP / DCP

Guidance for exchange of documentation relating to reference veterinary medicinal products between Member States

Informed consent

Best practice guide for Informed consent for MRP, SRP and DCP

Limited markets

Best Practice Guide for handling marketing authorisations for veterinary medicinal products intended for limited markets (national, mutual recognition and decentralised procedures)

Exceptional circumstances

Best Practice Guide for handling applications for marketing authorisations for veterinary medicinal products in exceptional circumstances (national, mutual recognition and decentralised procedures)

Duplicates

Guidance for duplicate applications in mutual recognition and decentralised procedures

 

Guidance documents – Directive 2001/82/EC

Generics 

Guidance for the processing of generic applications through MRP/DCP

Guidance for exchange of documentation relating to a reference veterinary medicinal product between MS

Definition of the term "same medicinal product"

Informed consent

Best practice guide Art. 13(c) informed consent applications

Line extension

Line extensions: Requirements for the content of the dossier - Quality part

Duplicates

Duplicate applications in mutual recognition and decentralised procedures

For the United Kingdom, as of 1 January 2021, European Union law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland / NI.

  • Useful Links
  • Privacy Policy
  • Credits & Disclaimer
  • Contact
© Heads of Medicines Agencies - https://www.hma.eu/veterinary-medicines/cmdv/procedural-guidance/applications-for-marketing-authorisation/advice-on-specific-application-types.html